Table 1.
Age Groups | Population (a) | 1st Dose (b) | % 1st Dose (b/a) |
Single Dose (c) | Recovered (d) | % (b + c + d)/a | 2nd Dose (e) | Vaccinated (c + e) | % (c + e)/a | Booster (f) |
% * (f) | Awaiting 1st Dose (g) |
% (g/a) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>80 | 4,594,071 | 4,329,833 | 94.3 | 112,339 | 18,802 | 97.1 | 4,230,789 | 4,343,128 | 94.5 | 3,894,111 | 92.0 | 243,409 | 2.9 |
70–79 | 6,016,425 | 5,401,790 | 89.8 | 313,664 | 41,315 | 95.7 | 5,295,672 | 5,609,336 | 93.2 | 5,101,201 | 94.3 | 259,656 | 4.3 |
60–69 | 7,532,302 | 6,361,805 | 84.5 | 681,949 | 104,899 | 94.9 | 6,208,509 | 6,890,458 | 91.5 | 6,055,845 | 93.4 | 383,649 | 5.1 |
50–59 | 9,645,296 | 8,035,467 | 83.3 | 736,513 | 244,758 | 93.5 | 7,796,666 | 8,533,179 | 88.5 | 6,957,435 | 89.8 | 628,558 | 6.5 |
40–49 | 8,781,291 | 7,125,115 | 81.1 | 512,269 | 270,431 | 90.0 | 6,923,603 | 7,435,872 | 84.7 | 5,322,066 | 81.7 | 873,476 | 10.0 |
30–39 | 6,790,908 | 5,631,064 | 82.9 | 380,114 | 215,770 | 91.7 | 5,432,991 | 5,813,105 | 85.6 | 3,644,952 | 75.6 | 563,960 | 8.3 |
20–29 | 6,029,273 | 5,234,190 | 86.8 | 362,727 | 159,336 | 95.5 | 5,048,743 | 5,411,470 | 89.78 | 3,306,083 | 72.5 | 273,020 | 4.5 |
12–19 | 4,620,379 | 3,759,039 | 81.4 | 191,533 | 241,634 | 90.7 | 3,525,927 | 3,717,460 | 80.5 | 1,517,430 | 55.2 | 428,173 | 9.3 |
* % of the population potentially targeted for an additional or booster dose who have completed their vaccination cycle for at least four months.